Yumoto Tetsuya, Oami Takehiko, Liang Zhe, Burd Eileen M, Ford Mandy L, Turner Jerrold R, Coopersmith Craig M
Department of Surgery and Emory Critical Care Center, Emory University, School of Medicine, Atlanta, Georgia.
Department of Pathology and Laboratory Medicine, Emory University, School of Medicine, Atlanta, Georgia.
Shock. 2025 Apr 1;63(4):597-605. doi: 10.1097/SHK.0000000000002531. Epub 2024 Dec 3.
Sepsis induces intestinal hyperpermeability, which is associated with higher mortality. Occludin is a tight junction protein that plays a critical role in regulating disease-associated intestinal barrier loss. This study examined the role of intestinal occludin on gut barrier function and survival in a preclinical model of sepsis. Intestinal epithelial-specific occludin knockout (occludin KO IEC ) mice and wild type controls were subjected to intra-abdominal sepsis and sacrificed at predetermined endpoints for mechanistic studies or followed for survival. Occludin KO IEC mice had a significant increase in intestinal permeability, which was induced only in the setting of sepsis as knockout mice and control mice had similar baseline permeability. The worsened barrier was specific to the leak pathway of permeability, without changes in either the pore or unrestricted pathways. Increased sepsis-induced permeability was associated with increased levels of the tight junction ZO-1 in occludin KO IEC mice. Occludin KO IEC mice also had significant increases in systemic cytokines IL-6 and MCP-1 and increased bacteremia. Furthermore, occludin KO IEC mice had higher levels of jejunal IL-1β and MCP-1 as well as increased MCP-1 and IL-17A in the peritoneal fluid although peritoneal bacteria levels were unchanged. Notably, 7-day mortality was significantly higher in occludin KO IEC mice following sepsis. Occludin thus plays a critical role in preserving gut barrier function and mediating survival during sepsis, associated with alterations in inflammation and bacteremia. Agents that preserve occludin function may represent a new therapeutic strategy in the treatment of sepsis.
脓毒症可导致肠道通透性增加,这与较高的死亡率相关。闭合蛋白是一种紧密连接蛋白,在调节与疾病相关的肠道屏障丧失中起关键作用。本研究在脓毒症临床前模型中研究了肠道闭合蛋白对肠道屏障功能和生存的作用。对肠道上皮特异性闭合蛋白敲除(闭合蛋白敲除IEC)小鼠和野生型对照进行腹腔内脓毒症造模,并在预定终点处死以进行机制研究,或观察其生存情况。闭合蛋白敲除IEC小鼠的肠道通透性显著增加,这仅在脓毒症情况下出现,因为敲除小鼠和对照小鼠的基线通透性相似。屏障功能恶化特定于通透性的渗漏途径,而孔隙或无限制途径均无变化。脓毒症诱导的通透性增加与闭合蛋白敲除IEC小鼠中紧密连接蛋白ZO-1水平升高有关。闭合蛋白敲除IEC小鼠的全身细胞因子IL-6和MCP-1水平也显著升高,菌血症增加。此外,尽管腹腔细菌水平未变,但闭合蛋白敲除IEC小鼠空肠IL-1β和MCP-1水平较高,腹腔液中MCP-1和IL-17A增加。值得注意的是,脓毒症后闭合蛋白敲除IEC小鼠的7天死亡率显著更高。因此,闭合蛋白在脓毒症期间维持肠道屏障功能和介导生存中起关键作用,与炎症和菌血症的改变有关。保留闭合蛋白功能的药物可能代表脓毒症治疗中的一种新治疗策略。